Department of General Anesthesia and Outcomes Research, The Cleveland Clinic, Ohio 44195, USA.
Curr Pharm Des. 2013;19(32):5792-808. doi: 10.2174/13816128113199990062.
Stroke is the third leading cause of death and the leading cause of disability in contemporary society. Aneurysmal subarachnoid hemorrhage (aSAH) is a hemorrhagic stroke which accounts for 7% of all stroke cases and 22 to 25% of cerebrovascular deaths. Aneurysmal subarachnoid hemorrhage is a very complex disease and many controversies on its pathophysiology and management have not yet been settled. The aim of this review is to present the most recent evidence-based advances in the pathophysiology and perioperative management of aSAH.
中风是当代社会的第三大致死原因和首要致残原因。蛛网膜下腔出血（aSAH）是一种出血性中风，占所有中风病例的 7%，占脑血管死亡的 22%至 25%。蛛网膜下腔出血是一种非常复杂的疾病，其病理生理学和治疗方面仍存在许多争议尚未解决。本篇综述旨在介绍蛛网膜下腔出血病理生理学和围手术期处理方面的最新循证进展。
